Nihon Kohden launches augmented reality app

Nihon Kohden, producers of various types of electronic equipment in medicine, has announced the launch of the its Dimensions Augmented Reality (AR) app.

The app, working with the Clinical Excellence Services from Nihon Kohden University (NKU), creates a computer-generated AR that allows clinicians to practice procedures. The life-like environment includes elements like sound, video and graphics taken from actual data to provide clinicians with a method to treat patients, teach and train staff.

“Nihon Kohden understands the incredible ever-changing role healthcare providers play in delivering quality patient care,” said Wilson P. Constantine, chief executive officer of Nihon Kohden America. “AR is a revolutionary new technology that has the potential to transform healthcare for physicians and patients alike. The interactive Nihon Kohden Dimensions app experience allows clinicians to learn our technology quickly with the ultimate goal of treating patients safely.”

The Nihon Kohden Dimensions app was awarded the AVA Digital Award 2018 Platinum Winner for Mobile App, an international competition for the production of digital communications. Currently, Dimensions are used with Nihon Kohden’s Lead Placement and Arrhythmia Identification posters. Users are able to use iOS mobile devices to scan the posters to launch the app. The session then leads users through correct lead placement using three to six lead sets or teaches users to identify common cardia arrhythmias.

“At Nihon Kohden, we are committed to ensuring a best-in-class educational experience for those we serve,” said Veffa Devers, vice president of clinical excellence programs for Nihon Kohden America. “The Nihon Kohden Dimensions app is intended to seamlessly incorporate education into the clinical care our end users provide, helping to improve clinical workflow and quality, and providing an exceptional customer experience.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup